GlaxoSmithKline Pharmaceuticals

Sector: Healthcare

Followers

0
0
9
9
.
3
3
5
5
4
4
,
2
2
34.10 (1.41%)

As on 17 Apr, 2026 | 15:58

Open Trading A/c
Day Range
2,410.00
2,465.40
LH
52 Week Range
2,217.60
3,515.70
LH
Volume
* i
Bid / Ask
42,722.00
0.00 / 0.00

GlaxoSmithKline Pharmaceuticals Announcements

GlaxoSmithKline Pharmaceuticals Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018

09 Apr, 2026 | 11:36am • Source: NSE

As per attachment

09 Apr, 2026 | 10:43am • Source: BSE

As per attachment

08 Apr, 2026 | 11:25pm • Source: BSE

As per attachment

25 Mar, 2026 | 03:03pm • Source: BSE

As per attachment

24 Mar, 2026 | 12:11pm • Source: BSE

As per attachment

16 Mar, 2026 | 05:58pm • Source: BSE

GlaxoSmithKline Pharmaceuticals Limited has informed the Exchange regarding Outcome of Board Meeting held on March 02, 2026

02 Mar, 2026 | 01:14pm • Source: NSE

As per attachment

02 Mar, 2026 | 12:17pm • Source: BSE

As per attachment

02 Mar, 2026 | 12:15pm • Source: BSE

As per attachment

28 Feb, 2026 | 04:06pm • Source: BSE

As per attachment

23 Feb, 2026 | 10:40am • Source: BSE

As per attachment

10 Feb, 2026 | 11:30am • Source: BSE

As attached

09 Feb, 2026 | 07:24pm • Source: BSE

Press Release

09 Feb, 2026 | 03:43pm • Source: BSE

Outcome of Meeting

09 Feb, 2026 | 03:31pm • Source: BSE

Outcome of Meeting

09 Feb, 2026 | 03:24pm • Source: BSE

As per attachment

03 Feb, 2026 | 10:20am • Source: BSE

GlaxoSmithKline Pharmaceuticals Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018

08 Jan, 2026 | 12:20pm • Source: NSE